# Maintenance Hormonal Therapy and DLBCL

> **NCT06355401** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Sohag University** · enrollment: 100 (estimated)

## Conditions studied

- Diffuse Large B Cell Lymphoma

## Interventions

- **DRUG:** Tamoxifen 20mg

## Key facts

- **NCT ID:** NCT06355401
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-04
- **Primary completion:** 2026-03
- **Final completion:** 2029-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06355401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06355401, "Maintenance Hormonal Therapy and DLBCL". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06355401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*